Lv621
2920 积分 2024-02-29 加入
Chemotherapeutic Drug—Antibody Conjugates (ChemoBodies): Recent Advances and Future Directions
17天前
已完结
Engineering multi-specific nano-antibodies for cancer immunotherapy
21天前
已完结
Research trends in the use of nanobodies for cancer therapy
22天前
已完结
The downstream purification of bispecific antibodies
1个月前
已完结
Efficiently scaled-up production of recombinant human elastin-like polypeptides using multiple optimization strategies
1个月前
已完结
Process optimization and scale-up of high-efficient biosynthesis for recombinant collagen-elastin fusion protein
1个月前
已完结
Heterologous expression of recombinant nattokinase in Escherichia coli BL21(DE3) and media optimization for overproduction of nattokinase using RSM
1个月前
已完结
Elranatamab: a new promising BispAb in multiple myeloma treatment
1个月前
已完结
Mechanistic prediction of first-in-human dose for bispecific CD3/EpCAM T-cell engager antibody M701, using an integrated PK/PD modeling method
1个月前
已完结
Optimization of recombinant neurturin expression in Escherichia coli using response surface methodology
1个月前
已完结
皖公网安备34019202002308
